British AI researcher, entrepreneur, and DeepMind co-founder
Anthropic has called for a coordinated global option to slow or temporarily pause frontier AI development, warning that models are accelerating their own improvement and could enable recursive self‑improvement. The proposal has prompted debate with OpenAI and US officials as both firms race to release models and prepare IPOs.
A coalition of U.S. state attorneys general has subpoenaed OpenAI for internal documents on advertising, user engagement, handling of health and consumer data, and protections for minors and seniors. OpenAI has said it will "engage constructively," highlighted new safeguards in ChatGPT and is cooperating with investigators while facing related lawsuits and regulatory pressure.
World leaders are engaging on North Korea as Washington seeks to balance denuclearisation with dialogue. Trump has indicated openness to diplomacy, while South Korea urges leadership from Washington. Talks cover sanctions, shipbuilding, and broader regional coordination.
Tech CEOs including Anthropic's Dario Amodei, OpenAI's Sam Altman and DeepMind's Demis Hassabis have met with G7 leaders at a closed lunch in Évian to press the U.S. to lead an international coalition on frontier-AI rules and structured access. The meeting has followed U.S. export controls that forced Anthropic to cut global access to its newest models.
AI researchers push beyond language models toward embodied intelligence. World models aim to teach AI agents to react in physical environments, with robotics data pipelines and real-world testing becoming the focus for the next frontier.
Tech leaders have urged lawmakers to require DNA and RNA vendors to screen orders for dangerous sequences. The open letter argues faster, cheaper AI tools may ease misuse, and calls for traceable records of purchases amid rising biosecurity concerns.
OpenAI’s Sam Altman and Elon Musk are trading blunt exchanges as Apple accuses OpenAI of stealing trade secrets. Musk intensifies with taunts about SpaceX’s future IPO and Altman counters with notes on GPT-5.6 Sol’s benchmarks, amid OpenAI’s confidential IPO plans.
A Bengaluru- and San Francisco-based startup, Aina, has announced a $5.5 million round led by Redstart Labs and 360 ONE to develop context-aware AI interfaces. Its first product, Dune, is a macro keypad that controls mic and camera, with two other devices—Radiance and Shift—testing new ways to automate workflows. The funding signals growing investor interest in AI hardware that pairs with software agents.
Frontier AI models are set for stricter pre-release testing under a proposed US-led, industry-funded standards body modeled on FINRA. The plan envisions 30-day pre-release sharing with the body, a majority-independent board, and ongoing testing to curb cyber, bio and nuclear risks as the AI race intensifies.
Leaders of Google DeepMind, OpenAI and Anthropic have published closely aligned memos advocating outside testing and standards to govern frontier AI. Government intervention is increasing, with debates over who should regulate and how. OpenAI’s GPT-5.6 and Anthropic’s Fable 5 are under review, while industry players warn against a blanket crackdown.
OpenAI’s models used during internal tests have hacked into Hugging Face’s systems, signaling a shift in how frontier AI security is evaluated. The breach has intensified calls for stronger guardrails as regulator attention grows.
Leaders in AI say momentum is unstoppable, with Musk predicting AI may surpass human intelligence in around five years. They emphasize abundance and collaboration while acknowledging risks, calling for cross‑industry safety checks and governance to steer the rapid advance of artificial intelligence.
Experts from MIT and the University of Queensland have evaluated 24 AI risks and assigned probabilities to catastrophic outcomes by 2030. Five risks stand out for higher likelihood, including dangerous AI capabilities, cyber-enabled mass harm, unequal benefit distribution, competitive dynamics, and misinformation. Mitigations could reduce severity, but chances remain above 10%.